Searched for
JUBILANT PHARMOVA STOCKS
JioBlackRock Flexi Cap Fund exits 3 AMC stocks, HAL, and 13 others in AprilJioBlackRock Mutual Fund’s Flexi Cap Fund completely exited 17 stocks in April, including AMC companies and Hindustan Aeronautics, while ad...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Dip buying: Sunil Singhania-backed Abakkus Flexi Cap Fund picks 1.4% stake in Heritage Foods in MarchAce Investor Sunil Singhania-backed Abakkus Flexi Cap Fund added Heritage Foods in the quarter ended March, picking nearly 13 lakh shares t...
- Stocks in news: Bajaj Finance, Kronox Lab, IDBI Bank, Dr Reddy's, Godawari Power, Jubilant PharmovaDomestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut w...
- Jubilant Pharmova shares jump over 6% on receiving USFDA approval for Technetium Sulfur Colloid InjectionFor this approval, Jubilant is eligible for 180 days of exclusivity through the ‘Competitive Generic Therapy’ designation from the US FDA.
- Buy Jubilant Pharmova, target price Rs 570: Axis SecuritiesJubilant Pharmova Ltd. key Products/Revenue Segments include Organic Chemicals, Other Operating Revenue and Sale of services for the year e...
- Paytm, RVNL and 5 other stocks surpass 50-day SMAThe crossing of the 50-day SMA by these companies reflects their resilience and potential for future growth, making them noteworthy contend...
- Adani Power, Laxmi Organic, 7 other stocks crossing 50-day SMAAs observed on July 28, 2023, stocks crossing their 50-day SMA have presented potential opportunities in various sectors, such as fintech, ...
- Jubilant Pharmova shares tumble over 11% as Q4 net loss widens sequentially to Rs 98 croreJubilant Pharmova's quarterly net loss widened to INR 98 crore in the March quarter of FY23 from a loss of INR 15.67 crore in the previous ...
- Big Movers on D-St: What should investors do with Jubilant Pharmova, Hindalco and Samvardhana Motherson?The texture of the chart formation and technical indicators such as RSI is indicating at a likely reversal from the current levels, which c...
- Stocks in news: Kirloskar Oil, SBI, Jubilant Pharmova, Adani Enterprises, Adani PowerThe entities belonging to the late Gautam Kulkarni family and part of the promoter group of Kirloskar Oil Engines Ltd have offloaded nearly...
- Buy Jubilant Pharmova, target price Rs 475: Anand RathiJubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceutica...
- Buy Jubilant Pharmova, target price Rs 417: ICICI SecuritiesJubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 5304.06 Crore) operating in Pharmace...
- Down 50% in 1 year! What's ahead for this Rakesh Jhunjhunwala stock?Analysts have cut FY23 earning estimates by over 20 per cent. They see a near-term hangover in terms of margin and USFDA observations but s...
- Down 55% from recent high, can this Jhunjhunwala stock stage recovery?Analysts said near to medium term growth would remain under pressure due to regulatory issues, slow recovery in the API business and inflat...
- Market movers: The curious case of buying and selling in BSE sharesJubilant Pharmova announced that one of its subsidiaries received Abbreviated New Drug Application (ANDA) final approval for Doxepin Hydroc...
- Why this Jhunjhunwala stock is seeing rating downgradesA few analysts believe revenues have bottomed out for drug maker Jubilant Pharmova, others do not hold high hopes in the short term
- Buy Jubilant Pharmova, target price Rs 920: Motilal OswalJubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 11241.27 Crore) operating in Pharmac...
- Buy Jubilant Pharmova, target price Rs 960: Motilal OswalJubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 12593.56 Crore) operating in Pharmac...
- Jubilant Pharmova surges as company develops Remdesivir oral formHospitals and pharmacists in major cities have reported acute shortage of the drug due to supply constraints and alleged hoarding.
Load More
